Global /India /Healthcare /Drug Manufacturers - General /KOPRAN
chevron_leftBack
Kopran Ltd. logo

Kopran Ltd.

KOPRAN
NSE: KOPRAN Delayed
164.63INR 4.8%
1.74 USD
As of 21 June 2026, Kopran Ltd. has a market cap of $80.14M USD, ranking #27126 globally and #1703 in India. It ranks #2436 in the Healthcare sector, and #877 in the Drug Manufacturers - General industry.
Global Rank
27126
Country Rank
1703
Sector Rank
2436
Industry Rank
877
Key Stats
Market Cap
$80.14MUSD
7.56B INR
Enterprise Value
$92.79MUSD
8.76B INR
Revenue (TTM)
$65.66MUSD
6.2B INR
EBITDA (TTM)
$5.88MUSD
554.76M INR
Net Income (TTM)
$1.75MUSD
165.43M INR
EBITDA Margin
9%
Profit Margin
2.7%
PE Ratio
45.7
PS Ratio
1.2
PB Ratio
1.5
EV/EBITDA
15.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Surendra Somani open_in_new
Employees
1,024
Founded
1958
Website
kopran.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
4.8% 2.9% 39% 21% -5.1% -22%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
KOPRAN
Kopran Ltd
ISIN: INE082A01010
Shares Out.:
48.286M1 Shares Float: 30.322M2
TV:
SA:
YF:
GF:
BA:
MS:
164.63 INR
Bombay Stock Exchange
MIC: XBOM
524280 (KOPRAN)
Kopran Ltd
ISIN: INE082A01010
TV:
SA:
YF:
GF:
BA:
MS:
164.70 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Kopran Ltd.

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, sterile carbapenem, urological, neuromodulator, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company offers drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
56K%
39.1
DIVISLAB
$18.38B
1.73T INR
23K%
70.0
$15.17B
1.43T INR
19K%
63.0
$11.73B
1.11T INR
15K%
19.6
MANKIND
$9.87B
931.67B INR
12K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
12K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
950K%
38.1
JNJ
$547.28B
683K%
26.4
ABBV
$360.63B
450K%
97.4
$318.3B
256.25B CHF
397K%
19.9
AZN
$284.64B
215.59B GBP
355K%
27.6
MRK
$274.03B
342K%
15.1
chevron_leftBack